Volume: 35

1. Correlation between 18F-FLT PET/CT imaging and microvessel density of tumor tissue in non-small cell lung cancer Page:1—4
2. Diagnostic value of 18F-FDG PET/CT for subsolid pulmonary nodules Page:5—9
3. 18F-FDG PET/CT imaging characteristics of Castleman's disease Page:14—17
4. Correlation between extratemporal hypometabolism and the outcome of temporal lobectomy in patients with temporal lobe epilepsy Page:18—21
5. Evaluation of the effect of 90Sr-90Y applicator treatment for hemangioma by superficial ultrasound Page:41—43
6. Relationship between the changes of biochemical markers of bone turnover and renal osteodystrophy in patients with primary nephrotic syndrome Page:44—47
7. Application of fluorescein sodium on Cerenkov radiation energy transfer Page:59—62
8. Development and status of quality control and standard for nuclear medicine imaging equipment Page:75—78
9. Relationship between myocardial glucose metabolism in right heart and cardiac function in patients with idiopathic dilated cardiomyopathy Page:81—84
10. Value of 11C-MET PET/CT in determinating conformal radiotherapeutic planning for high-grade gliomas Page:102—107
11. SPECT cerebral perfusion imaging and its quantitative analysis for the assessment of stent implantation for cerebral artery stenosis Page:108—111
12. Dynamic change of peripheral blood cell in patients with differentiated thyroid cancer before and after 131I treatment Page:116—119
13. Value of 18F-FDG PET/CT in the post-treatment evaluation of cervical cancer Page:164—167
14. Value of 18F-FDG PET/CT in the evaluation of treatment response and prognosis for patients with recurrent uterine cervical cancer Page:168—172
15. Clinical value of 125I seeds implantation combined with high intensity focused ultrasound for the treatment of portal vein tumor thrombus from hepatocellular carcinoma Page:182—185
16. 18F-FDG PET/CT in evaluating the radiosensitizing effect of oleanolic acid Page:217—221
17. Preparation of HER2 radioligand 99Tcm-ABH2 and its in vivo imaging in breast cancer-xenografted mice Page:222—226
18. Diagnostic value of 18F-FDG PET/CT delayed imaging after diuresis in patients with primary bladder tumor Page:10—13
19. Consistency of FDG uptake on 18F-FDG PET/CT and regional homogeneity on functional MRI in major depression disorder patients Page:27—31
20. Brain perfusion SPECT for therapeutic evaluation of patients with moyamoya disease after surgery Page:32—35
21. Targeting vulnerable plaque of experimental atherosclerosis models with 99Tcm-Duramycin Page:53—58
22. PET imaging in liver transplantation for primary hepatocarcinoma Page:71—74
23. Diagnostic value of 18F-FDG PET/CT in differentiating the cardiac benign from malignant lesions Page:85—87
24. Diagnostic value of 18F-FDG PET/CT in patients with pancreatic neoplasm Page:92—96
25. The effectiveness and influencing factors of 131I treatment for cervical lymph node metastases of papillary thyroid carcinoma Page:112—115
26. Targeting islet cell using 18F-Fallypride: in vitro and histoautoradiography study Page:131—134
27. Optimal preparation procedure and quality evaluation of the superparamagnetic iron oxide coated by dextran Page:139—144
28. Clinical significance of negative thyroglobulin and positive diagnostic whole body scan in patients with differentiated thyroid carcinoma who underwent thyroid remnant ablation Page:154—156
29. 18F-FDG PET/CT in evaluation of the outcome after stereotactic body radiation therapy for early-stage non-small cell lung cancer Page:157—160
30. Value of 18F-FDG PET/CT in patients with cancer of the uterine cervix having elevated serum squamous cell carcinoma antigen after treatment Page:173—176
31. Somatostatin receptor scintigraphy of orbital inflammatory pseudotumor associated with systemic vasculitis Page:190—194
32. Systolic synchrony of ischemic myocardium assessed by stress-rest 99Tcm-MIBI gated SPECT myocardial perfusion imaging Page:195—199
33. Radionuclide pulmonary perfusion and ventilation scan in pediatric patients with bronchiolitis obliterans Page:200—203
34. Synthesis and biodistribution of 11C-N-CH3-Dopamine as a new cardiac sympathetic nerve imaging agent Page:204—207
35. The effect of P-glycoprotein on 18F-FDG uptake in tumor-bearing nude mice Page:208—211
36. 18F-FDG PET/CT monitoring for early tumor response to cisplatin in VX2 tumor-bearing rabbits Page:212—216
37. The research progress of myocardial perfusion agent with 99TcmN core Page:237—240
38. Experimental study on multiple tracers PET/CT in the differentiation of C6 glioma from different inflammation Page:396—402
39. Impacts of infection status of hepatitis viruses and biochemical parameters of liver function on 18F-FDG uptake by the liver Page:254—257
40. 131I therapy for Graves disease: a comparative study for calculating the 131I-iodide activity based on radioactive iodine uptake formula and individualized experience method Page:272—275
41. Tumor inhibitory effects of 131I-Trastuzumab on human epidermal growth factor receptor 2 overexpressing breast cancer cells and its possible mechanisms Page:293—297
42. Influence of the cytosine content in liposome-coated 99Tcm-HYNIC-survivin ASODN on tumor bearing nude mice imaging Page:355—358
43. Clinical value of 99Tcm-MIBI scintigraphy in patients with differentiated thyroid carcinoma after surgery and first 131I therapy Page:383—386
44. Preliminary study on effective dose of patients in SPECT/CT fusion imaging Page:387—390
45. Synthesis and biodistribution of 99Tcm-Cetuximab antibody for lung tumor targeted molecular imaging Page:391—395
46. Differential diagnosis of rat C6 glioma and inflammation with 18F-FDG, 11C-MET and 11C-CHO PET/CT imaging and their correlations with HIF-1α and VEGF Page:340—345
47. Monitoring the migration of bone marrow derived mesenchymal stem cells to intracranial glioma by sodium iodide sympoter Page:346—350
48. Synthesis and preliminary evaluation of 18F-AIF-NOTA-G-TMTP1 for PET imaging on nude mice bearing high-metastatic potential hepatoma cells Page:351—354
49. Comparison of 13N-NH3 and 18F-FDG PET/CT in the evaluation of gliomas Page:374—378
50. Application of multimodal imaging in stem cell research Page:407—409
51. Application of 18F-FMISO for tumor hypoxia imaging Page:410—413
52. CT and 18F-FDG PET/CT features of pulmonary sclerosing hemangioma Page:251—253
53. Curative efficacy and influential factors of 131I treatment for lung metastases from differentiated thyroid carcinoma Page:258—261
54. Effect of taking L-T4 in bedtime vs morning on changes of serum thyroid hormone concentration in patients with hypothyroidism Page:265—267
55. Association between iodine intake and treatment outcomes of radioiodine remnant ablation in patients with papillary thyroid cancer Page:268—271
56. Diagnostic value of SPECT/CT for lumbar spondylolysis Page:280—283
57. Diagnostic value of 18F-FDG PET/CT for differentiating multiple myeloma from bone metastases with undetermined origin Page:284—288
58. In vitro study of type Ⅰ intron-mediated dual reporter gene imaging for carcinoembryonic antigen Page:298—302
59. Automated synthesis and quality analysis of 18F-FMISO based on CFN-MPS-100 module Page:303—305
60. The diagnostic value of 18F-FDG PET/CT in differentiated thyroid carcinoma Page:315—318
61. Progress of 99Tcm-labeled glucose and its analogs in tumor imaging Page:319—321
62. Progress on the clinical research of fluoro-3(2(S)-2-azetidinylmethoxy) pyridine and Iodo-3-(2(S)-azetidinylmethoxy) pyridine Page:322—325